Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Integrative Clinical Trials LLC

Neither a doctor nor a teaching hospital

Research payments

$1,977,724

335 payments

Through program year 2025, Integrative Clinical Trials LLC is reported as receiving $1,977,724 in research payments, across 335 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $585,395 93
2024 Research $221,289 12
2023 Research $287,035 4
2022 Research $190,058 77
2021 Research $365,376 77
2020 Research $241,127 43
2019 Research $87,442 29

Breakdown

Who paid Research payments · program years 2019–2025
  1. Janssen Research & Development, LLC $636,361 80 payments
  2. Sage Therapeutics, Inc. $579,966 85 payments
  3. Otsuka Pharmaceutical Development & Commercialization, Inc. $346,401 19 payments
  4. Allergan Inc. $176,152 32 payments
  5. ACADIA Pharmaceuticals Inc $50,377 8 payments
  6. Merz Pharmaceuticals, LLC $42,680 8 payments
  7. Bayer HealthCare Pharmaceuticals Inc. $26,876 20 payments
  8. Eisai Inc. $21,816 17 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $21,146 31 payments
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $19,812 3 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) $268,364 3 payments
  2. A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms $182,915 22 payments
  3. A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia an $182,647 19 payments
  4. A Phase 3, Multicenter, Randomized, Double-Blind Trial of Fixed-Dose Brexpiprazole As Combination Therapy With Sertraline in the Treatment of Adults With Post-Traumatic Stress Disorder $166,966 3 payments
  5. A Double-Blind, Placebo-Controlled Study of Cariprazine As Adjunctive Therapy in Major Depressive Disorder $150,496 23 payments
  6. A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso $115,013 18 payments
  7. A Phase 3, Open-Label, 1-Year Study of the Safety, Tolerability, and Need for Re-Treatment With Sage-217 in Adult Subjects With Major Depressive Disorder $108,552 39 payments
  8. A Comparative Study of Sage-217 Plus Sertraline Versus Placebo Plus Sertraline in Adults With Major Depressive Disorder $105,763 28 payments
  9. A Randomized, Double-blind, Multicenter, Placebo-controlled, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-89495120 as Monotherapy in Adult Participants with Major Depressive Disorder (MDD) $97,913 15 payments
  10. A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia VENTURA-5 $57,873 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record